Skip to content
Screener

OnKure Therapeutics, Inc. OKUR Q2 2026 earnings

Reported August 4, 2026 · After market close

EPS-$0.31Beat by $0.23
Revenue estimate$166.7K
EPS estimate-$0.54

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$166.7K
EPS estimate-$0.36

FAQ

When did OnKure Therapeutics, Inc. report Q2 2026 earnings?
OnKure Therapeutics, Inc. (OKUR) reported Q2 2026 earnings on August 4, 2026 after market close.
What were OnKure Therapeutics, Inc.'s Q2 2026 revenue and EPS?
OnKure Therapeutics, Inc. reported eps of $-0.31 for Q2 2026.
Did OnKure Therapeutics, Inc. beat estimates in Q2 2026?
EPS beat the consensus estimate of $-0.54 by $0.23.
How did OnKure Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 72.8% from $-1.14.
Where can I find OnKure Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-332809) and the 10-Q periodic report (0001193125-26-332773) directly on SEC EDGAR. The filing index links above go to sec.gov.